Drugs & medicalClass II

SOMERSET THERAPEUTICS LLC recalls Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC…

Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).

Read the official notice →
Date
2024-05-29
Country
United States
Brand
Somerset Therapeutics
Product
Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC…
Classification
Class II
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Somerset Therapeutics recalls

  1. 2026-03-25
  2. US
    Drugs & medicalClass II

    SOMERSET THERAPEUTICS LLC recalls Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for:…

    Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP…

    FDA · DrugSOMERSET THERAPEUTICS LLCNationwide in the USAOfficial notice →
  3. 2025-12-24
  4. US
    Drugs & medicalClass III

    SOMERSET THERAPEUTICS LLC recalls Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for:…

    Subpotent product:out of specification assay results observed during long term stability testing.

    FDA · DrugSOMERSET THERAPEUTICS LLCNationwide in the USAOfficial notice →
  5. 2025-01-08
  6. US
    Drugs & medicalClass III

    SOMERSET THERAPEUTICS LLC recalls Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873,…

    Failed Impurities/Degradation Specifications

    FDA · DrugSOMERSET THERAPEUTICS LLCNationwide within the United StatesOfficial notice →
All 4 Somerset Therapeutics recalls →

Other drugs & medical recalls in the United States

  1. 2024-05-29
  2. US
    Drugs & medicalClass I

    OptumHealth Care Solutions LLC recalls Optum Nimbus II Plus, Model number AAA-00170; Ambulatory Infusion Pump

    Nimbus II Plus, Infusion Pump Systems, manufactured by InfuTronix, are being removed the from the market due to multiple potential failure modes, including battery failure, upstream occlusion, system errors, drug…

    FDA · DeviceOptumHealth Care Solutions LLCUS Nationwide DistributionOfficial notice →
  3. US
    Drugs & medicalClass I

    Hikma Injectables USA Inc recalls Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36…

    Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

    FDA · DrugHikma Injectables USA IncCO, GA, PA, SD, WAOfficial notice →
  4. US
    Drugs & medicalClass II

    American Regent, Inc. recalls Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American…

    Subpotent product in addition to having out-of-specification results for impurities.

    FDA · DrugAmerican Regent, Inc.USA NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

    FDA · DrugPreferred Pharmaceuticals, Inc.Product distributed to CA, FL, OK, KS and CTOfficial notice →
  6. US
  7. US
See all drugs & medical recalls →